Newsroom

Sorted by: Latest

-

Young & Co's Brew. UK Regulatory Announcement: Transaction in Own Shares

LONDON--(BUSINESS WIRE)--  18 September 2026 YOUNG & CO'S BREWERY PLC ("Young’s", or the "Company") Transaction in Own Shares Young & Co.’s Brewery, P.L.C. (the “Company”) announces that between 11 September and 17 September, in accordance with the terms of its share buyback programme announced by the Company on 08 July 2026 (the “Share Buyback Programme”), it has purchased the following Non-voting ordinary shares of 12.5 pence each (“Non-voting Shares”) and A ordinary shares of 12.5 pe...
-

First Trust Portfolios UK Regulatory Announcement: First Trust Global Portfolios Management Limited Announces Distributions for certain sub-funds of First Trust Global Funds ICAV

LONDON--(BUSINESS WIRE)--  First Trust Global Portfolios Management Limited (“FTGPM”) announces the declaration of the distributions for the following sub-funds of First Trust Global Funds ICAV (the “ICAV”), ISIN Fund Name Frequency Dividend per Share IE00BWTNMB87 First Trust US Large Cap Core AlphaDEX® UCITS ETF Class B Quarterly 0.1983 (USD) IE00BWTNM966 First Trust Germany AlphaDEX® UCITS ETF Class A Quarterly 0.0294 (EUR) IE00BD9N0445 First Trust United Kingdom AlphaDEX® UCITS ETF Class B Q...
-

OBERON AIM VCT PLC UK Regulatory Announcement: Half-year Financial Report

LONDON--(BUSINESS WIRE)--  Oberon AIM VCT plc For the six months to 30 June 2026 Chairman’s Statement I am pleased to present you with an update for the first six months of our current year. The high volatility we are seeing in commodity prices and the ongoing geopolitical uncertainty in several regions of the world has not helped the backdrop of our portfolio’s performance during H1’26, which was disappointing, with a decline in value, on a per share basis, of about 16.3% during this period (u...
-

Pzena Investment Management, LLC UK Regulatory Announcement: Form 8.3 Tate & Lyle Plc

NEW YORK--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Pzena Investment Management, LLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries mus...
-

Shun Tak Holdings Limited Adopts Hyperides Managed Security Operations Center (SOC) Services to Strengthen Enterprise Cybersecurity Defense

HONG KONG--(BUSINESS WIRE)--As cyber threats become increasingly sophisticated and attack methods evolve rapidly, Shun Tak Holdings Limited continues to prioritize cybersecurity and data protection across its business operations. As a diversified conglomerate with core businesses spanning real estate, transportation, hospitality and leisure, and investments, the company has selected Hyperides Security Operations Center (SOC) services, incorporating Penetration Testing and Security Assessment se...
-

エリプティック、オンチェーン・リスクに関する質問に回答し、その根拠も示す「Decode」エージェントを発表

ニューヨーク--(BUSINESS WIRE)--(ビジネスワイヤ) -- エリプティックは、オンチェーン・リスク分野の世界的リーダーとして、同社のインテリジェンス・プラットフォームを基盤とするAIエージェント「Decode」を発表しました。Decodeエージェントは、暗号資産アドレスとそのエクスポージャーに関する自然言語の質問に数秒で回答し、すべての回答についてその根拠を提示します。 コンプライアンスおよび調査チームには、事前に想定されていなかった問いへの答えが必要です。データからその答えを引き出すには今や専門的なスキルが求められるため、そのスキルを持つ人が対応するまで質問は保留されるか、そもそも問われないままとなります。その一方で、不正行為者は機械の処理速度で活動し、決済の両側にエージェントが関与し始めています。 汎用AIアシスタントは答えを生成できます。しかし、その答えがどこから導かれたのかを示すことはできません。根拠のない流暢な回答を、第2線のレビュー担当者、監査人、規制当局に提示することはできません。 「市場には、信頼を求めるAIがあふれています。意思決定に至った経緯を問わ...
-

Elliptic lanza Decode para responder preguntas sobre riesgos en blockchain y mostrar cómo llega a sus conclusiones

NUEVA YORK--(BUSINESS WIRE)--Elliptic, referente mundial en gestión de riesgos en blockchain, lanzó hoy Decode, un agente de IA desarrollado sobre su plataforma de inteligencia. Decode responde en segundos a preguntas formuladas en lenguaje natural sobre direcciones de criptoactivos y su exposición a distintos riesgos, y proporciona las pruebas que respaldan cada respuesta. Los equipos de cumplimiento e investigación necesitan respuestas a preguntas que nadie había previsto. Extraerlas de los d...
-

MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination

LYON, France--(BUSINESS WIRE)--MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination...
-

Sensorion annonce les modalités de connexion pour son SENS-601 Program Day du 22 septembre 2026

MONTPELLIER, France & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Regulatory News: Sensorion (FR001401A9Z0 – ALSEN) (« la Société ») société pionnière de biotechnologie au stade clinique, spécialisée dans le développement de nouvelles thérapies pour restaurer, traiter et prévenir les troubles de la perte auditive, annonce aujourd'hui les modalités d'inscription et de connexion pour son SENS-601 Program Day, qui se tiendra le 22 septembre 2026. Comme précédemment annoncé, le SENS-601 Program Day sera con...
-

Sensorion Announces Connection Details for its SENS-601 Program Day on September 22, 2026

MONTPELLIER, France & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Regulatory News: Sensorion (FR001401A9Z0 – ALSEN) (“the Company”), a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today announces registration and connection details for its SENS-601 Program Day, to be held on September 22, 2026. As previously announced, the SENS-601 Program Day will be dedicated to the Company's SENS-601 program, i...